Concord Biotech informs about transcripts of earnings call

21 Feb 2025 Evaluate

In continuation of its letter dated February 14, 2025 regarding Audio recording of the Audited (Standalone and Consolidated) Financial Results of the company for the Third Quarter and Nine months ended December 31, 2024, Earnings call for Investors and Analysts and pursuant to Regulation 30 (6) of the SEBI (Listing Obligations and Disclosure Requirements) 2015, Concord Biotech has informed that it enclosed the transcripts of the Earnings call for the said period and available on the website of the company at the following link after sending this letter. Also, that this transcript and the audio recording of the call, both have been uploaded on its website as follows: https://www.concordbiotech.com/investors.

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

1339.30 171.70 (14.71%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×